CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-03 | Ocain Tim Senior Vice President | Exercise or conversion | +2,000 | $32.27 | $65K | 8,127 |
| 2018-12-03 | Ocain Tim Senior Vice President | Exercise or conversion · Stock Option (Right to Buy) | −2,000 | 58,000 | ||
| 2018-11-16 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2018-11-16 | Ocain Tim Senior Vice President | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2018-11-16 | MELLETT PAUL J Treasurer and CFO | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2018-11-16 | Adda Nathalie Sr. VP & Chief Medical Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-11-16 | Or Yat Sun Sr. VP & CSO | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-11-16 | Luly Jay R. President and CEO | Grant or award · Stock Option (right to buy) | +68,000 | 68,000 | ||
| 2018-10-01 | Ocain Tim Senior Vice President | Exercise or conversion | +15,000 | $19.98 | $300K | 21,127 |
| 2018-10-01 | Ocain Tim Senior Vice President | Exercise or conversion | +10,000 | $32.27 | $323K | 31,127 |
| 2018-10-01 | Ocain Tim Senior Vice President | Sale | −3,500 | $82.04 | $287K | 27,627 |
| 2018-10-01 | Ocain Tim Senior Vice President | Sale | −6,219 | $83.47 | $519K | 21,408 |
| 2018-10-01 | Ocain Tim Senior Vice President | Sale | −14,677 | $84.02 | $1.2M | 6,731 |
| 2018-10-01 | Ocain Tim Senior Vice President | Sale | −604 | $85.30 | $52K | 6,127 |
| 2018-10-01 | Ocain Tim Senior Vice President | Exercise or conversion · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2018-10-01 | Ocain Tim Senior Vice President | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 60,000 | ||
| 2018-10-01 | Gardiner Nathaniel S. Sr. VP & General Counsel | Exercise or conversion | +1,500 | $34.70 | $52K | 13,827 |
| 2018-10-01 | Gardiner Nathaniel S. Sr. VP & General Counsel | Exercise or conversion · Stock Option (right to buy) | −1,500 | 76,700 | ||
| 2018-09-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Exercise or conversion | +2,955 | $43.46 | $128K | 4,155 |
| 2018-09-20 | Adda Nathalie Sr. VP & Chief Medical Officer | Sale | −500 | $93.02 | $47K | 3,655 |
Page 26 of 31 · 619 trades